🔗 Share this article

This year's prestigious award in medical science has been awarded for revolutionary discoveries that clarify how the immune system targets dangerous infections while protecting the body's own cells.

A trio of renowned scientists—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research identified unique "sentinels" within the defense system that remove malfunctioning immune cells that could attacking the organism.

The discoveries are now enabling innovative therapies for autoimmune diseases and malignancies.

The winners will share a prize fund worth 11 million Swedish kronor.

Decisive Discoveries

"The research has been essential for understanding how the body's defenses operates and the reason we don't all suffer from severe autoimmune diseases," stated the head of the award panel.

The trio's studies address a core mystery: How does the immune system protect us from countless infections while keeping our own tissues unharmed?

The immune system employs white blood cells that search for signs of disease, even pathogens and germs it has not met before.

These defenders utilize detectors—called recognition units—that are generated randomly in countless variations.

This provides the defense network the capacity to combat a wide array of invaders, but the unpredictability of the mechanism unavoidably creates immune cells that can attack the body.

Security Guards of the Immune System

Researchers previously understood that a portion of these harmful white blood cells were eliminated in the immune organ—the site where immune cells mature.

This year's Nobel Prize honors the identification of T-reg cells—described as the body's "security guards"—which travel through the system to disarm any immune cells that attack the body's own tissues.

We know that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These findings have established a novel area of investigation and spurred the development of innovative therapies, for example for tumors and immune disorders."

In malignancies, T-regs prevent the body from fighting the growth, so studies are focused on lowering their quantity.

In autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is not being harmed. A similar approach could also be useful in reducing the risks of organ transplant failure.

Pioneering Experiments

Prof Sakaguchi, from Osaka University, performed tests on mice that had their thymus extracted, leading to autoimmune disease.

The researcher demonstrated that injecting immune cells from other mice could stop the illness—suggesting there was a system for blocking defenders from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in rodents and humans that led to the identification of a gene critical for how regulatory T-cells operate.

"Their pioneering research has uncovered how the immune system is controlled by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a leading physiology specialist.

"The work is a striking example of how fundamental biological research can have far-reaching implications for human health."